The biguanide metformin remains one of the most widely prescribed drugs worldwide, has long been a first-line defense in the treatment of insulin resistance and type 2 diabetes, and activates AMPK signaling in the liver (16). Here, PRKAA1 is linked to type 2 diabetes mellitus.